Other
Natural Killer Cell
0
Pipeline Programs↗
8
Active Trials↗
2
Companies Involved↗
Natural Killer Cell is an early-stage landscape with 0 programs across 2 companies. The most active players are NKGen Biotech, Inc., CHABiotech CO., Ltd.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
25
clinical trials
Completed7 · 28%
Unknown status5 · 20%
Terminated4 · 16%
Recruiting4 · 16%
Not yet recruiting2 · 8%
Active, not recruiting2 · 8%
Other1 · 4%
Clinical Trials
Trial Activity
25 trials
Effect of Prednisolone Treatment on Uterine Natural Killer Cells
Recruiting·—·Phase 3·NCT03902912·84 enrolled
Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML
Recruiting·—·Phase 1/2·NCT05272293·15 enrolled
Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
Recruiting·—·Phase 1/2·NCT05334693·15 enrolled
"Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients"
Active, not recruiting·IInstituto de Investigación Hospital Universitario La Paz·Phase 1/2·NCT05304754·18 enrolled
Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure
Not yet recruiting·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·Phase 2·NCT07230574·159 enrolled
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer
Completed·—·Phase 1·NCT00631072·9 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)